CA2170037C - Dehydration of hydrogels - Google Patents
Dehydration of hydrogels Download PDFInfo
- Publication number
- CA2170037C CA2170037C CA002170037A CA2170037A CA2170037C CA 2170037 C CA2170037 C CA 2170037C CA 002170037 A CA002170037 A CA 002170037A CA 2170037 A CA2170037 A CA 2170037A CA 2170037 C CA2170037 C CA 2170037C
- Authority
- CA
- Canada
- Prior art keywords
- implant
- water content
- relative humidity
- range
- dehydration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/441—Joints for the spine, e.g. vertebrae, spinal discs made of inflatable pockets or chambers filled with fluid, e.g. with hydrogel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/3011—Cross-sections or two-dimensional shapes
- A61F2002/30112—Rounded shapes, e.g. with rounded corners
- A61F2002/30133—Rounded shapes, e.g. with rounded corners kidney-shaped or bean-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30581—Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
- A61F2002/444—Intervertebral or spinal discs, e.g. resilient for replacing the nucleus pulposus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0015—Kidney-shaped, e.g. bean-shaped
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2329/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal, or ketal radical; Hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Derivatives of such polymer
- C08J2329/02—Homopolymers or copolymers of unsaturated alcohols
- C08J2329/04—Polyvinyl alcohol; Partially hydrolysed homopolymers or copolymers of esters of unsaturated alcohols with saturated carboxylic acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S264/00—Plastic and nonmetallic article shaping or treating: processes
- Y10S264/90—Direct application of fluid pressure differential to shape, reshape, i.e. distort, or sustain an article or preform and heat-setting, i.e. crystallizing of stretched or molecularly oriented portion thereof
- Y10S264/901—Heat-setting of stretched or molecularly oriented article formed from planar preform, e.g. sheet, film
Abstract
Novel prosthetic nuclear implants for insertion into vertebral discs are prepared by dehydrating hydrated bulky hydrogel discs under specific conditions so as to reduce the water content as low as possible (down to about 10 % by weight) but without distortion of the implants, without the formation of concavities and sharp edges, and without changing the shape of the hydrated implant.
Description
Field of the Invention This invention relates to bulky hydrogels and relates in particular to a method of preparation of prosthetic nuclei for vertebral discs.
Backsround of the Invention An important area of research in the field of medical devices is the development of a prosthetic nucleus for a vertebral disc. In U.S. Patent 5,047,055, a prosthetic nucleus for implanting in the disc space after the removal of a degenerated or damaged nucleus of an intervertebral disc is disclosed and claimed, as well as a method for forming the prosthetic nucleus.
In making such a prosthetic nucleus for insertion, the implants made of bulky hydrogels should be dehydrated so that they have a water content as low as possible.
This allows for easy insertion of the disc component during surgery due to the accompanying reduction in volume. Additionally, it is desirable for the implant to have no distortions (i.e., no concavities or dimplings formed therein) and it is desirable that the apparent volume (defined herein to be the volume that the disc would have if it had no concavities and is equal to the largest cross-section of the disc multiplied by the largest disc width) of the implant be a minimum. Furthermore, it is desirable that the implant have no sharp edges. It is especially important to have a minimum dehydrated volume for an implant which is to be inserted percutaneously.
However, it has been found that when the bulky hydrogels as disclosed in U.S.
5,047,055 are dehydrated so as to reduce the water content as low as possible, under certain conditions, gross distortions of the implants occur. These distortions may not be acceptable in the intended medical application. For example, sharp edges on the superior and inferior surfaces of the implants can cause damage on the end-plates of the natural disc.
It is an object of this invention to produce vertebral disc implants which have a water content as low as possible, which exhibit (to the naked eye) no visible distortion of the implants and no sharp edges, and which have a minimum apparent volume.
Another object of this invention is a method of dehydration of a bulky hydrogel implant so as to maintain the original shape of the hydrated implant.
Yet another object of this invention is an implant having a water content which is as low as possible (i.e., below about 10~) and which has a minimal apparent 2170~37 volume, no sharp edges, and no visible distortion (that is, no visible concavities) in the implant.
Yet another object of this invention is to dehydrate vertebral disc implants to a consistent geometry and size.
Summary of the Invention These and other objects of the invention are satisfied by the method of the invention for dehydration of bulky hydrogel nuclear vertebral implants which are of a size weighing between about 3 and about 10 grams and of a shape which is substantially in the shape of a kidney (that is, a shape similar to that of a human vertebral disc nucleus) comprising dehydrating these implants under controlled conditions of relative humidity and temperature and time such that when the water content of these implants is within a critical range of about 30 to about 60°~ by weight, the samples dry so that they avoid the formation of any cavities. Above a water content of about 60 weight percent and below about 30 weight percent water content, the dehydration appears to be not so critical and the dehydration can proceed without distortions, under ambient conditions. Unexpectedly, it has been found that for these implants of the specific size (most preferably about 5 grams), kidney shape, and specific materials (bulky hydrogels as set out fully in U.S. Patent 5,047,055 and described below), the conditions for drying are critical for the water content range of about 30-60°~ and should be (a) relative humidity of at least about 80%, preferably in the range from about 90 to about 99°~, and most preferably at least 95°~, (b) a drying temperature within the range from about 10° to about 40°C and preferably about room temperature to about 35°C, and (c) a time of drying sufficient to enable the samples to be dried without distortion to a water content below about 30°r6 and preferably to about 10°~6, the time being generally several days.
Such implants when dehydrated according to the method of the invention exhibit an apparent volume which is a minimum, no sharp edges, and no visible distortions (i.e., no concavity) in the implant. When the conditions used in the method of the invention are not used for dehydrating the implants in the critical range, the resultant implants have visible distortions, have sharp edges, and do not have an apparent volume which is minimal.
Also according to the invention, a bulky hydrogel implant suitable for implantation as an artificial nucleus in a vertebral disc has a water content less than about 30 weight percent, has no visible distortions, has no sharp edges, has a dehydrated weight within the range from about 0.5 g, to about 3.0 g. and has a shape which is substantially in the shape of a kidney.
Description of the Preferred Embodiments Description of the Drawings Figure 1 is a set of three graphs of water content (in percentage of water by weight) plotted versus time of dehydration (in days) of three samples of hydrogels (further described herein and in U.S. Patent 5,047,055 .
Graphs A and B are for controls and Graph C is for an implant of the invention dehydrated according to the method of the invention, using in this case a humidity chamber with a relative humidity of 9896 and a temperature of 35 ° C. Graphs 1A and 1 B are described in Example 1 and Graph 1 C is described in Example 2 (given below).
Figure 2 is a graph of water content versus time (in days) for an implant of the invention (dehydrated so that it has no distortions therein, no sharp edges, and a minimal apparent volume, formed as described in Example 3 by dehydrating the implant within a container which is alternately uncovered and then closed.
Fig. 3 is an enlarged drawing of a fully hydrated hydrogel vertebral nucleus implant of kidney shape before dehydration. The length AA is the width of the implant.
Fig. 4 is an enlarged drawing of a dehydrated vertebral nucleus implant. The implant was dehydrated under ambient conditions. The distortion concavity surfaces and sharp edges at the comers are visible. The length B is the width.
Fig. 5 is an enlarged drawing of a dehydrated vertebral nucleus implant of the invention which was dehydrated under the controlled conditions as described in Example 2. There is no visible distortion, concavity, or sharp edges. The length A is the width. The apparent volume of the implant in Fig. 5 is smaller than that in Fig. 4, and width B is larger than width A.
Figures 3, 4 and 5 are drawn to the same scale.
The particular materials which are used for the synthetic vertebral nuclear disc implants are fully described and set out in U.S. Patent No. 5,047,055 , As set out in that patent, the preferred material of the implants is a hydrogel material, preferably highly hydrolyzed polyvinyl alcohol (PVA).
The amount of hydrolization may be between about 95 and 10096, depending on the WO 95/07668 PCT/IB9:t100220 preferred final water content desired, which is about 70 to about 90 weight percent.
Generally the final hydrogel water content increases as the percent of hydrolization of the initial PVA decreases.
The method of preparing the prosthetic nucleus implants is fully set forth in U.S.
Patent 5,047,055. Also as disclosed in that patent, other hydrogels (besides preferred PVA) which can be used in the synthetic nucleus implants include other hydrogels such as lightly cross-linked polymers of 2-hydroxyethyl methacrylate, or copolymers and terpolymers made from the combination of the monomers of an N-vinyl monomer, (for example, N-vinyl-2-pyrrolidone(N-VP)), a hydroxy alkyl methacrylate ester (for example, 2-hydroxyethyl methacrylate (HEMA)), an alkyl methacrylate (for example, methyl methacrylate (MMA), an ethylenically unsaturated acid (for example, methacrylic acid (MA)) and an ethylenically unsaturated base (for example N,N-diethylamino ethyl methacrylate (DEAEMA)) may be used. In general, any hydrogel that can be used for soft contact lenses can be used for the synthetic nucleus implants as long as the hydrogel exhibits a compressive strength of at least 4MNm-2.
The size of the implants will generally be within the range of from about 3 to about 10 grams before dehydration, and preferably will be about 5 grams before dehydration.
The shape of the synthetic nuclear disc implants will be substantially in the shape of a kidney or any shape similar to the shape of a human vertebral disc nucleus.
The relative humidity suitable for use in the method of dehydrating the implants is a relative humidity in the atmosphere of at least 80°ro and preferably within the range from about 90 to 9996 and most preferably above 9896.
The temperature to be used in the dehydration method should be within the range from about 10 to about 40°C and preferably will be within the range from about 20 to about 35 ° C. The higher the temperature, the faster the water within the hydrated implants will diffuse to the surface of the implants.
It has been found that for the bulky hydrogels used in the implants, for the size of the implants, and for the shape of the implants, it is very important (if not critical) that when the water content of the implants is between about 30 and about 60 weight percent, the implants should be dehydrated with the humidity being controlled within the ranges as described above, and at the temperatures as described above, and for a length of time which is quite long so as to avoid deformation of the implants when 2i?Q03'~
they are being dehydrated. When the relative humidity is lowered, the time of dehydration can also be lowered. However, to provide good results, the time of drying will generally be at least several days (i.e., more than two but fewer than many).
Examale 1 i(Control~
A hydrogel prosthetic nucleus implant starting with a wet weight about 5 grams and with a water content of about 8596 was dehydrated under conditions of ambient temperature and humidity. Although the laboratory has air conditioning, the relative humidity was in the range of about 4596 to about 8596 during the period of the dehydration. The relative humidity each day during the dehydration period was recorded, and the averages are labeled in the plot. The room temperature was relatively stable (between 20-22°C). The high relative humidity (above 75°.6) in the first two days made this dehydration very slow during this period. The weight of the implant was monitored over the dehydration period, and the water content of the implant vs.
the time is plotted in Figure 1 (curve A). The shape of the implant was also monitored visually over time. In the early dehydration period when the implant still had high water content (wherein the water content was between about 8596 to about 6596), the implant maintained its original shape without distortion even though the water content (and thus the weight) of the implant decreased relatively quickly. In this range of water content, the implant remained very soft to the touch. As dehydration continued, the implant surfaces started to become rigid; and concavities became visible on the surfaces when the implant had a water content of about 50°~6. The concavities increased as the water content decreased further.
In Figure 1, curve B is the dehydration of a substantially similar implant dehydrated with low relative humidity (about 6096) in the same laboratory.
Again, concavities formed.
EXAMPLE 2 (Invention) A similar size hydrogel nucleus implant as was used as starting material in Example 1 was dehydrated in a Temperature/ Humidity controlled chamber, called a TH
Jr. (and manufactured by Tenny Engineering, Inc., Union, NJ) at 35°C
and at a relative humidity of 9896. The weight and the shape of the implant were checked over time.
' Water content vs. time is plotted in Figure 1, curve C. It can be seen that the dehydration rate was substantially decreased at high humidity, as compared with the rate of low humidity. The implant kept its original shape without the formation of any visible concavities even when the water content dropped to about 2596.
Next, the implant was dried further in a vacuum oven at 35°C. This further dehydration did not result in any visible concavity formation (as viewed by the naked .
eye).
EXAMPLE 3 (Invention) In this example, a hydrogel implant as was used as starting material in Example 1 but with a water content of about 7796 was first allowed to dehydrate quickly in air until the water content was about 5496. This occurred over about one day, and the relative humidity of the air was between 20-40°~6. Then, the implant was kept in a small closed container for the next three days. Then the implant was exposed to air again (with a relative humidity of 20-4096 for a period of about one day) and more water evaporated. Next, the hydrogel implant was placed in the container again.
These steps were repeated until the water content of the implant was about 3096.
Then the implant was allowed to dehydrate further under vacuum. (This further dehydration could have been done alternatively in air but for a longer period of time.) The implant dehydrated in this way provided a dehydrated implant (with water content of less than 10 weight 96) with no concavity on the surfaces.
Backsround of the Invention An important area of research in the field of medical devices is the development of a prosthetic nucleus for a vertebral disc. In U.S. Patent 5,047,055, a prosthetic nucleus for implanting in the disc space after the removal of a degenerated or damaged nucleus of an intervertebral disc is disclosed and claimed, as well as a method for forming the prosthetic nucleus.
In making such a prosthetic nucleus for insertion, the implants made of bulky hydrogels should be dehydrated so that they have a water content as low as possible.
This allows for easy insertion of the disc component during surgery due to the accompanying reduction in volume. Additionally, it is desirable for the implant to have no distortions (i.e., no concavities or dimplings formed therein) and it is desirable that the apparent volume (defined herein to be the volume that the disc would have if it had no concavities and is equal to the largest cross-section of the disc multiplied by the largest disc width) of the implant be a minimum. Furthermore, it is desirable that the implant have no sharp edges. It is especially important to have a minimum dehydrated volume for an implant which is to be inserted percutaneously.
However, it has been found that when the bulky hydrogels as disclosed in U.S.
5,047,055 are dehydrated so as to reduce the water content as low as possible, under certain conditions, gross distortions of the implants occur. These distortions may not be acceptable in the intended medical application. For example, sharp edges on the superior and inferior surfaces of the implants can cause damage on the end-plates of the natural disc.
It is an object of this invention to produce vertebral disc implants which have a water content as low as possible, which exhibit (to the naked eye) no visible distortion of the implants and no sharp edges, and which have a minimum apparent volume.
Another object of this invention is a method of dehydration of a bulky hydrogel implant so as to maintain the original shape of the hydrated implant.
Yet another object of this invention is an implant having a water content which is as low as possible (i.e., below about 10~) and which has a minimal apparent 2170~37 volume, no sharp edges, and no visible distortion (that is, no visible concavities) in the implant.
Yet another object of this invention is to dehydrate vertebral disc implants to a consistent geometry and size.
Summary of the Invention These and other objects of the invention are satisfied by the method of the invention for dehydration of bulky hydrogel nuclear vertebral implants which are of a size weighing between about 3 and about 10 grams and of a shape which is substantially in the shape of a kidney (that is, a shape similar to that of a human vertebral disc nucleus) comprising dehydrating these implants under controlled conditions of relative humidity and temperature and time such that when the water content of these implants is within a critical range of about 30 to about 60°~ by weight, the samples dry so that they avoid the formation of any cavities. Above a water content of about 60 weight percent and below about 30 weight percent water content, the dehydration appears to be not so critical and the dehydration can proceed without distortions, under ambient conditions. Unexpectedly, it has been found that for these implants of the specific size (most preferably about 5 grams), kidney shape, and specific materials (bulky hydrogels as set out fully in U.S. Patent 5,047,055 and described below), the conditions for drying are critical for the water content range of about 30-60°~ and should be (a) relative humidity of at least about 80%, preferably in the range from about 90 to about 99°~, and most preferably at least 95°~, (b) a drying temperature within the range from about 10° to about 40°C and preferably about room temperature to about 35°C, and (c) a time of drying sufficient to enable the samples to be dried without distortion to a water content below about 30°r6 and preferably to about 10°~6, the time being generally several days.
Such implants when dehydrated according to the method of the invention exhibit an apparent volume which is a minimum, no sharp edges, and no visible distortions (i.e., no concavity) in the implant. When the conditions used in the method of the invention are not used for dehydrating the implants in the critical range, the resultant implants have visible distortions, have sharp edges, and do not have an apparent volume which is minimal.
Also according to the invention, a bulky hydrogel implant suitable for implantation as an artificial nucleus in a vertebral disc has a water content less than about 30 weight percent, has no visible distortions, has no sharp edges, has a dehydrated weight within the range from about 0.5 g, to about 3.0 g. and has a shape which is substantially in the shape of a kidney.
Description of the Preferred Embodiments Description of the Drawings Figure 1 is a set of three graphs of water content (in percentage of water by weight) plotted versus time of dehydration (in days) of three samples of hydrogels (further described herein and in U.S. Patent 5,047,055 .
Graphs A and B are for controls and Graph C is for an implant of the invention dehydrated according to the method of the invention, using in this case a humidity chamber with a relative humidity of 9896 and a temperature of 35 ° C. Graphs 1A and 1 B are described in Example 1 and Graph 1 C is described in Example 2 (given below).
Figure 2 is a graph of water content versus time (in days) for an implant of the invention (dehydrated so that it has no distortions therein, no sharp edges, and a minimal apparent volume, formed as described in Example 3 by dehydrating the implant within a container which is alternately uncovered and then closed.
Fig. 3 is an enlarged drawing of a fully hydrated hydrogel vertebral nucleus implant of kidney shape before dehydration. The length AA is the width of the implant.
Fig. 4 is an enlarged drawing of a dehydrated vertebral nucleus implant. The implant was dehydrated under ambient conditions. The distortion concavity surfaces and sharp edges at the comers are visible. The length B is the width.
Fig. 5 is an enlarged drawing of a dehydrated vertebral nucleus implant of the invention which was dehydrated under the controlled conditions as described in Example 2. There is no visible distortion, concavity, or sharp edges. The length A is the width. The apparent volume of the implant in Fig. 5 is smaller than that in Fig. 4, and width B is larger than width A.
Figures 3, 4 and 5 are drawn to the same scale.
The particular materials which are used for the synthetic vertebral nuclear disc implants are fully described and set out in U.S. Patent No. 5,047,055 , As set out in that patent, the preferred material of the implants is a hydrogel material, preferably highly hydrolyzed polyvinyl alcohol (PVA).
The amount of hydrolization may be between about 95 and 10096, depending on the WO 95/07668 PCT/IB9:t100220 preferred final water content desired, which is about 70 to about 90 weight percent.
Generally the final hydrogel water content increases as the percent of hydrolization of the initial PVA decreases.
The method of preparing the prosthetic nucleus implants is fully set forth in U.S.
Patent 5,047,055. Also as disclosed in that patent, other hydrogels (besides preferred PVA) which can be used in the synthetic nucleus implants include other hydrogels such as lightly cross-linked polymers of 2-hydroxyethyl methacrylate, or copolymers and terpolymers made from the combination of the monomers of an N-vinyl monomer, (for example, N-vinyl-2-pyrrolidone(N-VP)), a hydroxy alkyl methacrylate ester (for example, 2-hydroxyethyl methacrylate (HEMA)), an alkyl methacrylate (for example, methyl methacrylate (MMA), an ethylenically unsaturated acid (for example, methacrylic acid (MA)) and an ethylenically unsaturated base (for example N,N-diethylamino ethyl methacrylate (DEAEMA)) may be used. In general, any hydrogel that can be used for soft contact lenses can be used for the synthetic nucleus implants as long as the hydrogel exhibits a compressive strength of at least 4MNm-2.
The size of the implants will generally be within the range of from about 3 to about 10 grams before dehydration, and preferably will be about 5 grams before dehydration.
The shape of the synthetic nuclear disc implants will be substantially in the shape of a kidney or any shape similar to the shape of a human vertebral disc nucleus.
The relative humidity suitable for use in the method of dehydrating the implants is a relative humidity in the atmosphere of at least 80°ro and preferably within the range from about 90 to 9996 and most preferably above 9896.
The temperature to be used in the dehydration method should be within the range from about 10 to about 40°C and preferably will be within the range from about 20 to about 35 ° C. The higher the temperature, the faster the water within the hydrated implants will diffuse to the surface of the implants.
It has been found that for the bulky hydrogels used in the implants, for the size of the implants, and for the shape of the implants, it is very important (if not critical) that when the water content of the implants is between about 30 and about 60 weight percent, the implants should be dehydrated with the humidity being controlled within the ranges as described above, and at the temperatures as described above, and for a length of time which is quite long so as to avoid deformation of the implants when 2i?Q03'~
they are being dehydrated. When the relative humidity is lowered, the time of dehydration can also be lowered. However, to provide good results, the time of drying will generally be at least several days (i.e., more than two but fewer than many).
Examale 1 i(Control~
A hydrogel prosthetic nucleus implant starting with a wet weight about 5 grams and with a water content of about 8596 was dehydrated under conditions of ambient temperature and humidity. Although the laboratory has air conditioning, the relative humidity was in the range of about 4596 to about 8596 during the period of the dehydration. The relative humidity each day during the dehydration period was recorded, and the averages are labeled in the plot. The room temperature was relatively stable (between 20-22°C). The high relative humidity (above 75°.6) in the first two days made this dehydration very slow during this period. The weight of the implant was monitored over the dehydration period, and the water content of the implant vs.
the time is plotted in Figure 1 (curve A). The shape of the implant was also monitored visually over time. In the early dehydration period when the implant still had high water content (wherein the water content was between about 8596 to about 6596), the implant maintained its original shape without distortion even though the water content (and thus the weight) of the implant decreased relatively quickly. In this range of water content, the implant remained very soft to the touch. As dehydration continued, the implant surfaces started to become rigid; and concavities became visible on the surfaces when the implant had a water content of about 50°~6. The concavities increased as the water content decreased further.
In Figure 1, curve B is the dehydration of a substantially similar implant dehydrated with low relative humidity (about 6096) in the same laboratory.
Again, concavities formed.
EXAMPLE 2 (Invention) A similar size hydrogel nucleus implant as was used as starting material in Example 1 was dehydrated in a Temperature/ Humidity controlled chamber, called a TH
Jr. (and manufactured by Tenny Engineering, Inc., Union, NJ) at 35°C
and at a relative humidity of 9896. The weight and the shape of the implant were checked over time.
' Water content vs. time is plotted in Figure 1, curve C. It can be seen that the dehydration rate was substantially decreased at high humidity, as compared with the rate of low humidity. The implant kept its original shape without the formation of any visible concavities even when the water content dropped to about 2596.
Next, the implant was dried further in a vacuum oven at 35°C. This further dehydration did not result in any visible concavity formation (as viewed by the naked .
eye).
EXAMPLE 3 (Invention) In this example, a hydrogel implant as was used as starting material in Example 1 but with a water content of about 7796 was first allowed to dehydrate quickly in air until the water content was about 5496. This occurred over about one day, and the relative humidity of the air was between 20-40°~6. Then, the implant was kept in a small closed container for the next three days. Then the implant was exposed to air again (with a relative humidity of 20-4096 for a period of about one day) and more water evaporated. Next, the hydrogel implant was placed in the container again.
These steps were repeated until the water content of the implant was about 3096.
Then the implant was allowed to dehydrate further under vacuum. (This further dehydration could have been done alternatively in air but for a longer period of time.) The implant dehydrated in this way provided a dehydrated implant (with water content of less than 10 weight 96) with no concavity on the surfaces.
Claims (14)
OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A method of dehydrating a bulky hydrogel nuclear vertebral implant weighing before dehydration in the range between 3 and 10 grams, having a shape substantially in the shape of a kidney and having a water content within the range from 30 to 90% by weight, which method comprises:
dehydrating the implant, wherein when the implant has a water content of between 30 and 60% by weight, the implant is dehydrated at a relative humidity of at least about 80% at a drying temperature within the range from 10 to 40°C and for a time of drying which is more than 2 days and is sufficient to enable the implant to be dried without distortion to a water content below 30%.
dehydrating the implant, wherein when the implant has a water content of between 30 and 60% by weight, the implant is dehydrated at a relative humidity of at least about 80% at a drying temperature within the range from 10 to 40°C and for a time of drying which is more than 2 days and is sufficient to enable the implant to be dried without distortion to a water content below 30%.
2. The method according to claim 1, wherein the implant is made of bulky hydrogel material selected from the group consisting of hydrogels that can be used for soft contact lenses provided that the hydrogel exhibits a compressive strength of at least 4 MNm-2, wherein the relative humidity is within the range from about 90 to about 99% and wherein the drying temperature is within the range from about 20 to about 35°C.
3. The method according to claim 2, wherein the relative humidity is at least about 95%.
4. The method according to any one of claims 1 to 3, wherein the dehydration takes place within a humidity chamber.
5. The method according to any one of claims 1 to 4, wherein the hydrogel is of polyvinyl alcohol having a degree of hydrolyzation of 95 to 100%.
6. The method according to any one of claims 1 to 5, in which the bulky hydrogel nuclear vertebral implant before the dehydration at the specified relative humidity and drying temperature has a water content within the range from 70 to 90%
by weight; and which further comprises a preliminary drying of the implant to reduce the water content to about 60% by weight prior to the dehydration step at the specified relative humidity and drying temperature.
by weight; and which further comprises a preliminary drying of the implant to reduce the water content to about 60% by weight prior to the dehydration step at the specified relative humidity and drying temperature.
7. The method according to claim 6, wherein the preliminary drying prior to the dehydration step is conducted at a relative humidity of 20 to 40%.
8. The method according to any one of claims 1 to 5, wherein the bulky hydrogel nuclear vertebral implant has a water content within the range from 70 to 90% and is subjected as it is to the dehydration at the specified relative humidity and drying temperature.
9. The method according to any one of claims 1 to 8, wherein the bulky hydrogel nuclear vertebral implant after the dehydration step at the specified relative humidity and drying temperature has a water content of 25% and is subjected to a further drying in a vacuum to reduce the water content to 10%.
10. A method of dehydrating a bulky hydrogel nuclear vertebral implant weighing before dehydration in the range between 3 and 10 grams, having a shape substantially in the shape of a kidney and having a water content within the range from 70 to 90% by weight, which method comprises:
a preliminary drying of the implant at a relative humidity less than 80% until the water content becomes about 60% by weight; and a further dehydration of the implant at a relative humidity of at least about 80% at a drying temperature within the range from 10 to 40°C and for a time of drying which is more than 2 days and is sufficient to enable the implant to be dried without distortion to a water content below 30%.
a preliminary drying of the implant at a relative humidity less than 80% until the water content becomes about 60% by weight; and a further dehydration of the implant at a relative humidity of at least about 80% at a drying temperature within the range from 10 to 40°C and for a time of drying which is more than 2 days and is sufficient to enable the implant to be dried without distortion to a water content below 30%.
11. The method according to claim 10, wherein the relative humidity of the preliminary drying is 20 to 40%.
12. The method according to claim 10 or 11, wherein the further dehydration consists of a plurality of steps each conducted under the specified conditions with a step of exposure of the implant to air at a relative humidity of 20 to 40%
between the steps under the specified conditions so that the water content of the implant after the plurality of the steps becomes below 30%.
between the steps under the specified conditions so that the water content of the implant after the plurality of the steps becomes below 30%.
13. A method of dehydrating a bulky hydrogel nuclear vertebral implant weighing before dehydration in the range between 3 and 10 grams, having a shape substantially in the shape of a kidney and having a water content within the range from 70 to 90% by weight, which method comprises:
a dehydration of the implant at a relative humidity of at least about 80% at a drying temperature within the range from 10 to 40°C and for a time of drying which is more than 2 days and is sufficient to enable the implant to be dried without distortion to a water content below 30%.
a dehydration of the implant at a relative humidity of at least about 80% at a drying temperature within the range from 10 to 40°C and for a time of drying which is more than 2 days and is sufficient to enable the implant to be dried without distortion to a water content below 30%.
14. The method according to any one of claims 10 to 13, which additionally comprises:
further drying the implant in a vacuum oven until the water content becomes about 10%.
further drying the implant in a vacuum oven until the water content becomes about 10%.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/122,110 US5522898A (en) | 1993-09-16 | 1993-09-16 | Dehydration of hydrogels |
US08/122,110 | 1993-09-16 | ||
PCT/IB1994/000220 WO1995007668A1 (en) | 1993-09-16 | 1994-07-18 | Dehydration of hydrogels |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2170037A1 CA2170037A1 (en) | 1995-03-23 |
CA2170037C true CA2170037C (en) | 2000-05-30 |
Family
ID=22400676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002170037A Expired - Fee Related CA2170037C (en) | 1993-09-16 | 1994-07-18 | Dehydration of hydrogels |
Country Status (7)
Country | Link |
---|---|
US (1) | US5522898A (en) |
EP (1) | EP0719117B1 (en) |
JP (1) | JP2935572B2 (en) |
AT (1) | ATE162385T1 (en) |
CA (1) | CA2170037C (en) |
DE (2) | DE9490462U1 (en) |
WO (1) | WO1995007668A1 (en) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030008396A1 (en) * | 1999-03-17 | 2003-01-09 | Ku David N. | Poly(vinyl alcohol) hydrogel |
GB9713330D0 (en) * | 1997-06-25 | 1997-08-27 | Bridport Gundry Plc | Surgical implant |
DE29720022U1 (en) * | 1997-11-12 | 1998-01-15 | Schaefer Micomed Gmbh | Intervertebral implant |
US5932552A (en) | 1997-11-26 | 1999-08-03 | Keraplast Technologies Ltd. | Keratin-based hydrogel for biomedical applications and method of production |
US6123731A (en) | 1998-02-06 | 2000-09-26 | Osteotech, Inc. | Osteoimplant and method for its manufacture |
US6224630B1 (en) * | 1998-05-29 | 2001-05-01 | Advanced Bio Surfaces, Inc. | Implantable tissue repair device |
US6605294B2 (en) | 1998-08-14 | 2003-08-12 | Incept Llc | Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels |
US6152943A (en) * | 1998-08-14 | 2000-11-28 | Incept Llc | Methods and apparatus for intraluminal deposition of hydrogels |
US6520996B1 (en) | 1999-06-04 | 2003-02-18 | Depuy Acromed, Incorporated | Orthopedic implant |
FR2897259B1 (en) | 2006-02-15 | 2008-05-09 | Ldr Medical Soc Par Actions Si | INTERSOMATIC TRANSFORAMINAL CAGE WITH INTERBREBAL FUSION GRAFT AND CAGE IMPLANTATION INSTRUMENT |
US20040024465A1 (en) | 1999-08-18 | 2004-02-05 | Gregory Lambrecht | Devices and method for augmenting a vertebral disc |
US8323341B2 (en) | 2007-09-07 | 2012-12-04 | Intrinsic Therapeutics, Inc. | Impaction grafting for vertebral fusion |
US7972337B2 (en) | 2005-12-28 | 2011-07-05 | Intrinsic Therapeutics, Inc. | Devices and methods for bone anchoring |
US7553329B2 (en) | 1999-08-18 | 2009-06-30 | Intrinsic Therapeutics, Inc. | Stabilized intervertebral disc barrier |
IL155494A0 (en) | 1999-08-18 | 2003-11-23 | Intrinsic Therapeutics Inc | Devices and method for nucleus pulposus augmentation and retention |
US7094258B2 (en) | 1999-08-18 | 2006-08-22 | Intrinsic Therapeutics, Inc. | Methods of reinforcing an annulus fibrosis |
US7717961B2 (en) | 1999-08-18 | 2010-05-18 | Intrinsic Therapeutics, Inc. | Apparatus delivery in an intervertebral disc |
US7998213B2 (en) | 1999-08-18 | 2011-08-16 | Intrinsic Therapeutics, Inc. | Intervertebral disc herniation repair |
EP1624832A4 (en) | 1999-08-18 | 2008-12-24 | Intrinsic Therapeutics Inc | Devices and method for augmenting a vertebral disc nucleus |
US6371984B1 (en) | 1999-09-13 | 2002-04-16 | Keraplast Technologies, Ltd. | Implantable prosthetic or tissue expanding device |
US6783546B2 (en) | 1999-09-13 | 2004-08-31 | Keraplast Technologies, Ltd. | Implantable prosthetic or tissue expanding device |
US6264695B1 (en) * | 1999-09-30 | 2001-07-24 | Replication Medical, Inc. | Spinal nucleus implant |
DK1244388T3 (en) * | 1999-12-06 | 2007-05-14 | Warsaw Orthopedic Inc | Device for treating intervertebral discs |
JP2006516199A (en) * | 2002-09-24 | 2006-06-29 | ボゴミール ゴレンセク | Stabilization apparatus and method for intervertebral disc |
AU2004249291B2 (en) | 2003-06-20 | 2009-07-23 | Intrinsic Therapeutics, Inc. | Device and method for delivering an implant through an annular defect in an intervertebral disc |
US20040260300A1 (en) | 2003-06-20 | 2004-12-23 | Bogomir Gorensek | Method of delivering an implant through an annular defect in an intervertebral disc |
CA2558623C (en) | 2004-02-06 | 2013-04-16 | Georgia Tech Research Corporation | Surface directed cellular attachment |
WO2005077304A1 (en) | 2004-02-06 | 2005-08-25 | Georgia Tech Research Corporation | Load bearing biocompatible device |
ATE506919T1 (en) * | 2004-03-26 | 2011-05-15 | Nuvasive Inc | DISC PROSTHESIS |
JP2007530120A (en) * | 2004-03-26 | 2007-11-01 | ヌヴァシヴ インコーポレイテッド | Porous implant for spinal disc nucleus pulposus replacement |
US20080269900A1 (en) * | 2004-05-20 | 2008-10-30 | Christopher Reah | Surgical Implants |
US20050277921A1 (en) * | 2004-05-28 | 2005-12-15 | Sdgi Holdings, Inc. | Prosthetic joint and nucleus supplement |
EP1786486B1 (en) * | 2004-09-10 | 2011-05-18 | Stichting Dutch Polymer Institute | Radiopaque prosthetic intervertebral disc nucleus |
GB0514891D0 (en) * | 2005-07-20 | 2005-08-24 | Pearsalls Ltd | Improvements in and relating to implants |
US20090105826A1 (en) * | 2005-06-03 | 2009-04-23 | Mcleod Alan | Surgical Implants |
CA2610871A1 (en) | 2005-06-06 | 2006-12-14 | The General Hospital Corporation | Tough hydrogels |
US20070093906A1 (en) * | 2005-10-26 | 2007-04-26 | Zimmer Spine, Inc. | Nucleus implant and method |
US8038920B2 (en) * | 2006-01-25 | 2011-10-18 | Carticept Medical, Inc. | Methods of producing PVA hydrogel implants and related devices |
US8603171B2 (en) * | 2006-01-25 | 2013-12-10 | Mimedx Group, Inc. | Spinal disc implants with flexible keels and methods of fabricating implants |
US20070179615A1 (en) * | 2006-01-31 | 2007-08-02 | Sdgi Holdings, Inc. | Intervertebral prosthetic disc |
US20070179618A1 (en) * | 2006-01-31 | 2007-08-02 | Sdgi Holdings, Inc. | Intervertebral prosthetic disc |
US7918889B2 (en) * | 2006-02-27 | 2011-04-05 | Warsaw Orthopedic, Inc. | Expandable spinal prosthetic devices and associated methods |
US7942104B2 (en) * | 2007-01-22 | 2011-05-17 | Nuvasive, Inc. | 3-dimensional embroidery structures via tension shaping |
US7946236B2 (en) * | 2007-01-31 | 2011-05-24 | Nuvasive, Inc. | Using zigzags to create three-dimensional embroidered structures |
US20100320639A1 (en) * | 2007-02-08 | 2010-12-23 | Christopher Reah | Medical Implants with Pre-Settled Cores and Related Methods |
US20100210752A1 (en) * | 2007-04-23 | 2010-08-19 | The General Hospital Corporation | Pva hydrogels having improved creep resistance, lubricity, and toughness |
WO2008131451A2 (en) * | 2007-04-24 | 2008-10-30 | The General Hospital Corporation Dba | Pva-paa hydrogels |
US8282681B2 (en) * | 2007-08-13 | 2012-10-09 | Nuvasive, Inc. | Bioresorbable spinal implant and related methods |
US20110196492A1 (en) | 2007-09-07 | 2011-08-11 | Intrinsic Therapeutics, Inc. | Bone anchoring systems |
US20090088723A1 (en) * | 2007-09-28 | 2009-04-02 | Accessclosure, Inc. | Apparatus and methods for treating pseudoaneurysms |
US8377135B1 (en) | 2008-03-31 | 2013-02-19 | Nuvasive, Inc. | Textile-based surgical implant and related methods |
CA3048437C (en) | 2011-05-26 | 2022-06-21 | Cartiva, Inc. | Tapered joint implant and related tools |
WO2016161026A1 (en) | 2015-03-31 | 2016-10-06 | Cartiva, Inc. | Carpometacarpal (cmc) implants and methods |
CA2981061A1 (en) | 2015-03-31 | 2016-10-06 | Cartiva, Inc. | Hydrogel implants with porous materials and methods |
EP3282961A4 (en) | 2015-04-14 | 2018-12-05 | Cartiva, Inc. | Tooling for creating tapered opening in tissue and related methods |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3234659A (en) * | 1961-05-08 | 1966-02-15 | Fan Air Systems Inc | Low temperature, high humidity method of lumber drying in a kiln |
US3760045A (en) * | 1967-12-12 | 1973-09-18 | H Thiele | Process of preparing shaped optical bodies useful as aids to vision |
JPS5956446A (en) * | 1982-09-24 | 1984-03-31 | Nippon Oil Co Ltd | Method for lowering flexibility of frozen polyvinyl alcohol gel |
JPH0678460B2 (en) * | 1985-05-01 | 1994-10-05 | 株式会社バイオマテリアル・ユニバース | Porous transparent polyvinyl alcohol gel |
JPH0611290B2 (en) * | 1986-11-05 | 1994-02-16 | 住友ベークライト株式会社 | Γ-ray sterilization method for polyvinyl alcohol gel |
US5047055A (en) * | 1990-12-21 | 1991-09-10 | Pfizer Hospital Products Group, Inc. | Hydrogel intervertebral disc nucleus |
JP3007903B2 (en) * | 1991-03-29 | 2000-02-14 | 京セラ株式会社 | Artificial disc |
-
1993
- 1993-09-16 US US08/122,110 patent/US5522898A/en not_active Expired - Lifetime
-
1994
- 1994-07-18 EP EP94919808A patent/EP0719117B1/en not_active Expired - Lifetime
- 1994-07-18 AT AT94919808T patent/ATE162385T1/en active
- 1994-07-18 DE DE9490462U patent/DE9490462U1/en not_active Expired - Lifetime
- 1994-07-18 CA CA002170037A patent/CA2170037C/en not_active Expired - Fee Related
- 1994-07-18 JP JP7509075A patent/JP2935572B2/en not_active Expired - Fee Related
- 1994-07-18 WO PCT/IB1994/000220 patent/WO1995007668A1/en active IP Right Grant
- 1994-07-18 DE DE69408153T patent/DE69408153T2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5522898A (en) | 1996-06-04 |
EP0719117A1 (en) | 1996-07-03 |
ATE162385T1 (en) | 1998-02-15 |
DE69408153D1 (en) | 1998-02-26 |
EP0719117B1 (en) | 1998-01-21 |
WO1995007668A1 (en) | 1995-03-23 |
CA2170037A1 (en) | 1995-03-23 |
JPH08509891A (en) | 1996-10-22 |
DE9490462U1 (en) | 1996-05-30 |
JP2935572B2 (en) | 1999-08-16 |
DE69408153T2 (en) | 1998-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2170037C (en) | Dehydration of hydrogels | |
AU686855B2 (en) | Hydrogel intervertebral disc nucleus | |
JP3544975B2 (en) | High refractive index hydrogels and uses thereof | |
US5705780A (en) | Dehydration of hydrogels | |
AU649758B2 (en) | Composite intraocular lens and method of manufacture | |
CA1339604C (en) | Synthetic intraocular lens swellable in swelling agent and a method for preparation thereof | |
WO2013134007A2 (en) | Improved polymers and methods for ophthalmic applications | |
EP1083844A1 (en) | Intraocular lens | |
US5717049A (en) | High refractive index hydrogels prepared from polymers and copolymers of N-benzyl-N-methylacrylamide | |
EP0796626B1 (en) | Intraocular lens formed of crosslinked polymethyl methacrylate and process for the production thereof | |
EP0474627B1 (en) | Deswelled, hydrogel intraocular lenses | |
EP0359829B1 (en) | Process for producing intraocular lens for correcting cyanopia | |
EP1208393B1 (en) | Covalently-bound, hydrophilic coating compositions for implants | |
US20020082372A1 (en) | Covalently-bound, hydrophilic coating compositions for surgical implants | |
EP1207808B1 (en) | Hydrophobically-bound, hydrophilic coating compositions for surgical implants | |
MXPA02006841A (en) | Coating of implantable ophthalmic lenses to reduce edge glare. | |
JPH03193058A (en) | Intraocular hydrogel lens with shape memory |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20140718 |